Fig. 2 | Scientific Reports

Fig. 2

From: Nomogram for predicting post-transarterial chemoembolization survival in recurrent patients with hepatitis B virus-associated hepatocellular carcinoma

Fig. 2

Multivariate analysis and forest plot of the hazard ratio of PRS in the training cohort. BCLC, Barcelona Clinic Liver Cancer; HBV, hepatitis B virus; MLR, monocyte-lymphocyte ratio; NLR, neutrophil-lymphocyte ratio; PLR, platelet-lymphocyte ratio; PRS, post-recurrence survival; SIRI, systemic inflammatory response index; TACE, transarterial chemoembolization.

Back to article page